Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Biomerica Inc BMRA

Healthcare Medical Devices

Biomerica, Inc. is a biomedical technology company. The Company develops, patents, manufactures and markets advanced diagnostic and therapeutic products used at the point-of-care (in home and in physicians’ offices) and in hospital/clinical laboratories for detection and/or treatment of medical conditions and diseases. It is also engaged in the research, development, commercialization and in... see more

Add To Watchlist

Recent & Breaking News (NDAQ:BMRA)

Biomerica's Fast 15-Minute Easy to Use COVID-19 Antigen Test Now Available With Simple Nasal Swab

GlobeNewswire May 11, 2021

Biomerica Reports 208% Increase In Q3 Fiscal 2021 Sales, Over Q3 Fiscal 2020

GlobeNewswire April 15, 2021

Biomerica Reports Fiscal 2021 Second Quarter Financial Results and Provides Business Update

GlobeNewswire January 15, 2021

Biomerica's Fast 15-Minute Simple to Use Covid-19 Antigen Rapid Test Receives CE Mark

GlobeNewswire January 12, 2021

Biomerica's InFoods® Irritable Bowel Syndrome Diagnostic-Guided Therapy Clinical Trial Nears Completion of Enrollment

GlobeNewswire December 9, 2020

Biomerica Reports Fiscal 2021 1st Quarter Financial Results

GlobeNewswire October 16, 2020

Biomerica Reports Fiscal Year End May 31, 2020 Financial Results

GlobeNewswire September 1, 2020

LD Micro 360 Companies Set to Present this Week

Accesswire August 31, 2020

Biomerica Announces Retirement of Chief Financial Officer (CFO), hiring of new CFO and appointment of new member to the Board of Directors

GlobeNewswire August 31, 2020

Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) and Provides Progress Update on COVID-19 antibody tests

GlobeNewswire August 12, 2020

LD Micro Announces Preliminary List of Presenters for the LD 500

Accesswire August 5, 2020

Biomerica Announces Filing of New Three Year Shelf Registration Statement

GlobeNewswire July 22, 2020

The University of Texas Health Science Center at Houston joins Biomerica's InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy ("DGT") clinical trial

GlobeNewswire June 29, 2020

Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19

GlobeNewswire June 16, 2020

Mayo Clinic joins Biomerica's InFoods® Irritable Bowel Syndrome ("IBS") Diagnostic-Guided Therapy clinical trial

GlobeNewswire June 1, 2020

Biomerica Receives CE mark for New High-Volume Version of 10 Minute Test for COVID-19 Exposure and Expands International Distribution

GlobeNewswire May 7, 2020

Biomerica Announces Third Quarter Financial Results

GlobeNewswire April 15, 2020

Biomerica Signs Two Definitive Agreements with Mount Sinai Medical School in New York to Scale-up a Laboratory Version Serological Test for COVID-19 That Enables High-Volume Screenings in Labs

GlobeNewswire April 2, 2020

Biomerica Begins Shipping Samples of 10 Minute Test for COVID-19 Virus Exposure

GlobeNewswire March 17, 2020

Biomerica Announces $2.0 Million Investment by Palm Global Small Cap Master Fund

GlobeNewswire February 26, 2020